PropertyValue
?:definition
  • A chemotherapy drug combination consisting of everolimus and gefitinib. Everolimus is a proliferation inhibitor with immunosuppressive and anti-angiogenic properties. Gefitinib is a epidermal growth factor receptor (EGFR) inhibitor with anti-angiogenic activity. This combination chemotherapy may result in increased tumor cell death compared to the use of either agent alone. Check for \'https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48388\' active clinical trials using this agent. (\'http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48388\' NCI Thesaurus)
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C1541292_PDQ>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C1541292_PDQ>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all